A detailed history of Central Trust CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Central Trust CO holds 46 shares of CRL stock, worth $8,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46
Previous 46 -0.0%
Holding current value
$8,491
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$194.44 - $217.61 $8,944 - $10,010
46 New
46 $9,000
Q4 2021

Feb 08, 2022

SELL
$351.38 - $448.68 $116,306 - $148,513
-331 Reduced 98.22%
6 $2,000
Q3 2021

Oct 19, 2021

BUY
$372.64 - $458.3 $111,792 - $137,490
300 Added 810.81%
337 $139,000
Q2 2021

Jul 23, 2021

SELL
$294.17 - $371.65 $1,470 - $1,858
-5 Reduced 11.9%
37 $13,000
Q1 2021

Apr 23, 2021

SELL
$249.67 - $299.48 $1,248 - $1,497
-5 Reduced 10.64%
42 $12,000
Q4 2020

Jan 29, 2021

SELL
$222.0 - $252.62 $1,776 - $2,020
-8 Reduced 14.55%
47 $11,000
Q3 2020

Oct 22, 2020

SELL
$175.56 - $226.45 $702 - $905
-4 Reduced 6.78%
55 $12,000
Q2 2020

Jul 14, 2020

SELL
$118.84 - $189.72 $12,121 - $19,351
-102 Reduced 63.35%
59 $10,000
Q1 2020

Apr 17, 2020

BUY
$98.9 - $178.34 $1,087 - $1,961
11 Added 7.33%
161 $20,000
Q4 2019

Jan 21, 2020

SELL
$126.05 - $152.76 $9,453 - $11,457
-75 Reduced 33.33%
150 $22,000
Q3 2019

Oct 28, 2019

SELL
$125.07 - $143.67 $490,274 - $563,186
-3,920 Reduced 94.57%
225 $30,000
Q2 2019

Jul 12, 2019

BUY
$123.4 - $148.55 $492,983 - $593,457
3,995 Added 2663.33%
4,145 $0
Q4 2018

Jan 08, 2019

BUY
$105.09 - $137.23 $2,101 - $2,744
20 Added 15.38%
150 $16,000
Q2 2018

Jul 09, 2018

SELL
$102.37 - $117.25 $28,151 - $32,243
-275 Reduced 67.9%
130 $0
Q1 2018

Apr 04, 2018

BUY
$98.19 - $115.2 $39,766 - $46,656
405 New
405 $0

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.39B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.